Vector-borne diseases (VBDs) pose a significant public health challenge in India, with a high prevalence rate and substantial morbidity and mortality. This article provides a comprehensive overview of the current landscape of VBDs in India and offers practical guidance for their effective management.
India faces a high burden of VBDs such as Malaria, Dengue, Chikungunya, and Japanese Encephalitis. Climatic conditions, environmental factors, and socio-economic disparities contribute to the widespread prevalence of these diseases. Malaria alone accounts for a significant proportion of morbidity and mortality, with the northeastern states being the most affected.
The management of VBDs in India is fraught with challenges, including inadequate public health infrastructure, lack of awareness, and socio-economic factors. Additionally, the emergence of drug-resistant strains and the lack of effective vaccines for many VBDs further complicate the situation.
Effective management of VBDs requires a multifaceted approach, encompassing robust surveillance, early detection, prompt treatment, and vector control. Strengthening the public health infrastructure, enhancing community awareness, and promoting research for new drugs and vaccines are crucial for managing VBDs.
Healthcare professionals play a pivotal role in the management of VBDs. This includes early diagnosis, appropriate treatment, patient education, and participation in public health initiatives. They also have a crucial role in research and policy-making, contributing to the development of effective strategies for VBD control.
Vector-borne diseases remain a significant public health concern in India, requiring concerted efforts for effective management. Healthcare professionals are at the forefront of these efforts, playing a critical role in disease control and prevention. Continued focus on strengthening public health infrastructure, enhancing community awareness, and research is imperative for managing the burden of VBDs in India.
1.
Talquetamab Combos Show Survival Benefit in r/r Myeloma
2.
From sweetener to cancer fighter? Fermented stevia shows promise in pancreatic cancer study
3.
Year in Review: Non-Small Cell Lung Cancer
4.
FINAL USPSTF RECOMMENDATIONS ON ANXIETY, DEPRESSION, AND SUIICIDAL RISK.
5.
Liposomal Chemo Combination No Better Than Standard Induction in Pediatric AML
1.
Targeted Therapies for Breast Cancer: What’s New?
2.
Ultrasound: A Promising Tool in the Fight Against Malignant Breast Cancer
3.
Adjuvant Atezolizumab in TNBC: What Recent Trials Reveal About Its Role
4.
Revolutionizing Cancer Care: The Transformative Role of AI and Data Science in Oncology
5.
Sorafenib: Understanding the science behind a powerful cancer drug
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
4.
Common Cancer Myths Debunked
5.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation